The government maintains the option of ordering an additional 36 million doses. Moderna still expects to deliver up to 56 million doses of the vaccine to Canadians by the beginning of 2021, according to the company.

The agreement comes on the heels of Moderna enrolling about 75% of participants in its phase III COVE study and 11,879 participants have received their second vaccinations as of September 18.

Moderna, Vertex collaborate on gene editing therapies for cystic fibrosis
Moderna and Vertex Pharmaceuticals have entered a three-year research collaboration for the discovery and development of lipid nanoparticles and messenger...

Moderna to potentially supply Japan with 40M doses of COVID-19 vaccine
Moderna is in discussion with the Ministry of Health, Labour, and Welfare of Japan to potentially purchase 40 million or more doses of its messenger...

U.S. to pay $1.5B for Moderna's COVID-19 vaccine
The U.S. government awarded a maximum $1.525 billion contract to Moderna to secure 100 million doses of its messenger RNA COVID-19 vaccine.

Amazon powers Moderna's digital biotech platform
Amazon Web Services is providing cloud, analytics, and machine-learning services to Moderna for its messenger RNA platform and manufacturing facility.

Animal study turns in positive results for Moderna-NIH COVID-19 vaccine
Moderna's COVID-19 vaccine candidate, messenger RNA (mRNA)-1273, has been shown to induce immune responses and control upper and lower respiratory tract...